Develops peripheral nerve interfaces and implantable devices for prosthetic control and sensory feedback.
Joint venture between GSK and Verily developing bioelectronic medicines that modulate peripheral nerves for chronic disease treatment.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →